G. Nogueras Gonzalez

The University of Texas MD Anderson Cancer Center

Papers

1

Total Citations

23

H-Index

1

About

G. Nogueras Gonzalez is a leading clinical researcher specializing in prostate cancer pathology, risk stratification, and the predictive modeling of disease progression. Their most cited work, a landmark 2019 study, addresses the critical clinical challenge of Gleason score discordance between prostate biopsy and radical prostatectomy specimens—a phenomenon known as “regression to the mean.” By leveraging routine clinical features, Nogueras Gonzalez developed a predictive framework that not only quantifies the likelihood of upgrading or downgrading but also correlates these shifts with biochemical relapse rates. This contribution has profound implications for treatment planning, helping clinicians avoid both overtreatment and undertreatment of localized prostate cancer. With 23 citations, this paper has become a key reference in urologic oncology. Nogueras Gonzalez’s work bridges the gap between biopsy-derived risk assessment and final pathology, offering a more nuanced, data-driven approach to patient counseling. Their research continues to shape how the field interprets Gleason scoring variability, directly influencing clinical guidelines and improving prognostic accuracy for men with prostate cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
23
Total Citations
23
Avg Citations/Paper
🏆 Most Cited Paper
Prostate cancer upgrading or downgrading of biopsy Gleason scores at radical prostatectomy: prediction of “regression to the mean” using routine clinical features with correlating biochemical relapse rates
23 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago